Market Overview:
The global amiodarone hydrochloride API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, and growing demand for amiodarone hydrochloride tablets and capsules. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global amiodarone hydrochloride API market can be segmented into purity>98% and purity98% segment is expected to account for a larger share of this market in 2018 owing to its higher quality as compared with other types available in the market. Based on application, this market can be divided into amiodarone hydrochloride tablets, capsules, and injection products. The tablet products segment is anticipated to account for a larger share of this market in 2018 due to their growing demand across regions worldwide.
Product Definition:
-Amiodarone Hydrochloride API is a class III antiarrhythmic agent. It is used for the treatment of atrial fibrillation, ventricular tachycardia, and supraventricular tachycardia.
Purity>98%:
Purity 98% is a new term in the amiodarone hydrochloride API market. It means that the product has been analyzed and confirmed to contain more than 98% of an active ingredient. The purity level is tested by various methods, such as High-performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Mass Spectrometry (MS).
Purity
Purity levels of 98% or more are considered as high purity, and less than 98% is considered to be low purity. Purity level of an amiodarone hydrochloride API is a key parameter that reflects the quality and standards of a product. It mainly depends on the extraction process used for manufacturing raw material, which in turn affects the final yield and quality of APIs.
Application Insights:
Amiodarone tablets were the most prominent application segment and accounted for a revenue share of over 60.0% in 2017. The product is used to treat arrhythmia, heart block and other cardiac disorders. It is also used as an anti-arrhythmic drug in the treatment of patients suffering from atrial fibrillation or flutter which results in reduction of blood flow through the heart which can lead to tissue damage if untreated. Amiodarone hydrochloride capsules are expected to witness significant growth owing to its usage as a second line therapy after transcatheter ablation for treating life-threatening ventricular tachyarrhythmias such as VF (ventricular fibrillation) andVT (ventricular tachycardia).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing cases of heart failure and other cardiac diseases coupled with rising awareness about amiodarone hydrochloride tablets, capsules and syrup. Moreover, presence of key manufacturers such as Pfizer Inc.; Actavis plc; and Merck & Co., Inc.
Asia Pacific is anticipated to be one of the fastest-growing regions during the same period owing to rapid economic development along with improving healthcare infrastructure in emerging countries such as China and India.
Growth Factors:
- Increasing prevalence of arrhythmia: The increasing prevalence of arrhythmia is one of the key growth drivers for the Amiodarone Hydrochloride API market. Arrhythmia is a condition in which the heart beats too fast, too slow, or irregularly. It can cause problems such as chest pain, shortness of breath, and heart failure. According to a study by American Heart Association (AHA), around 2% of the global population suffers from arrhythmia and this number is expected to increase in future due to rising incidence of lifestyle diseases such as obesity and diabetes mellitus. This will create significant demand for Amiodarone Hydrochloride API in coming years.
- Growing geriatric population: The growing geriatric population is another major growth driver for the Amiodarone Hydrochloride API market. As people age, their risk for developing cardiovascular diseases increases significantly owing to various physiological changes that occur in the body with aging such as loss in muscle mass and increase in fat mass etcetera Geriatrics are also more likely to have other risk factors for heart disease such as hypertension, high cholesterol levels etcetera This will create significant demand for Amiodarone Hydrochloride API over next few years across globe..
Scope Of The Report
Report Attributes
Report Details
Report Title
Amiodarone Hydrochloride API Market Research Report
By Type
Purity>98%, Purity<98%
By Application
Amiodarone Hydrochloride Tablets, Amiodarone Hydrochloride Capsules, Amiodarone Hydrochloride Tablets Injection
By Companies
Piramal Pharma Limited, Olon, Glenmark Pharma, CTX Lifesciences, PMC Isochem, Zhejiang Sanmen Hengka, United Pharma Industri, Cambrex, Shanghai Pharmaceutical Group Co., Ltd, Unichem Laboratories Limited, Arevipharma, Globe Quimica Ltda, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Amiodarone Hydrochloride API Market Report Segments:
The global Amiodarone Hydrochloride API market is segmented on the basis of:
Types
Purity>98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Amiodarone Hydrochloride Tablets, Amiodarone Hydrochloride Capsules, Amiodarone Hydrochloride Tablets Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Piramal Pharma Limited
- Olon
- Glenmark Pharma
- CTX Lifesciences
- PMC Isochem
- Zhejiang Sanmen Hengka
- United Pharma Industri
- Cambrex
- Shanghai Pharmaceutical Group Co., Ltd
- Unichem Laboratories Limited
- Arevipharma
- Globe Quimica Ltda
- Sanofi
Highlights of The Amiodarone Hydrochloride API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity>98%
- Purity<98%
- By Application:
- Amiodarone Hydrochloride Tablets
- Amiodarone Hydrochloride Capsules
- Amiodarone Hydrochloride Tablets Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amiodarone Hydrochloride API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amiodarone Hydrochloride API is a prescription medication used to treat heart rhythm disorders, such as atrial fibrillation (AF), ventricular tachycardia (VT), and flutter. It is also used to prevent these conditions from returning after they have been treated. Amiodarone Hydrochloride API can be given as an injection into a vein, or by mouth.
Some of the key players operating in the amiodarone hydrochloride api market are Piramal Pharma Limited, Olon, Glenmark Pharma, CTX Lifesciences, PMC Isochem, Zhejiang Sanmen Hengka, United Pharma Industri, Cambrex, Shanghai Pharmaceutical Group Co., Ltd, Unichem Laboratories Limited, Arevipharma, Globe Quimica Ltda, Sanofi.
The amiodarone hydrochloride api market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amiodarone Hydrochloride API Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Amiodarone Hydrochloride API Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Amiodarone Hydrochloride API Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Amiodarone Hydrochloride API Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Amiodarone Hydrochloride API Market Size & Forecast, 2020-2028 4.5.1 Amiodarone Hydrochloride API Market Size and Y-o-Y Growth 4.5.2 Amiodarone Hydrochloride API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity>98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Amiodarone Hydrochloride Tablets
6.2.2 Amiodarone Hydrochloride Capsules
6.2.3 Amiodarone Hydrochloride Tablets Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amiodarone Hydrochloride API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amiodarone Hydrochloride API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity>98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Amiodarone Hydrochloride Tablets
9.10.2 Amiodarone Hydrochloride Capsules
9.10.3 Amiodarone Hydrochloride Tablets Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity>98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Amiodarone Hydrochloride Tablets
10.10.2 Amiodarone Hydrochloride Capsules
10.10.3 Amiodarone Hydrochloride Tablets Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity>98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Amiodarone Hydrochloride Tablets
11.10.2 Amiodarone Hydrochloride Capsules
11.10.3 Amiodarone Hydrochloride Tablets Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity>98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Amiodarone Hydrochloride Tablets
12.10.2 Amiodarone Hydrochloride Capsules
12.10.3 Amiodarone Hydrochloride Tablets Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity>98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Amiodarone Hydrochloride Tablets
13.10.2 Amiodarone Hydrochloride Capsules
13.10.3 Amiodarone Hydrochloride Tablets Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amiodarone Hydrochloride API Market: Competitive Dashboard
14.2 Global Amiodarone Hydrochloride API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Piramal Pharma Limited
14.3.2 Olon
14.3.3 Glenmark Pharma
14.3.4 CTX Lifesciences
14.3.5 PMC Isochem
14.3.6 Zhejiang Sanmen Hengka
14.3.7 United Pharma Industri
14.3.8 Cambrex
14.3.9 Shanghai Pharmaceutical Group Co., Ltd
14.3.10 Unichem Laboratories Limited
14.3.11 Arevipharma
14.3.12 Globe Quimica Ltda
14.3.13 Sanofi